bioRxivCancer BiologyPreprint
A ribosomal pseudouridine drives an oncogenic translation program
Laurence Faucher‐GiguèreiD, Andrew RiveraiD, Baudouin S de PrévaliD, Étienne Fafard-CoutureiD, Gabrielle Deschamps-FrancoeuriD, Virginie MarchandiD, Yuri MotoriniD, Charles BarchetiD, Bruno P. KlaholziD, Taha AzadiD, Michelle S. ScottiD, Sherif Abou ElelaiD
- Citations
- 0
Abstract
Ribosome heterogeneity can regulate translation, but how changes in ribosome chemistry reshape cellular programs and contribute to diseases such as cancer remains incompletely understood. Here we show that SNORA81-guided pseudouridylation at a single 28S ribosomal RNA site, U4636, links ribosome heterogeneity to selective translation and ovarian cancer cell proliferation. This partially modified site contacts eL31 near the peptide-exit region. SNORA81 depletion reduces U4636 pseudouridylation and changes ribosome occupancy in relation to codon identity and nascent-peptide properties without broadly disrupting rRNA processing or bulk polysome profiles. Depletion also redistributes mRNAs with distinct GC content and amino-acid composition across polysomes, with corresponding protein-abundance changes in selected cancer-associated targets. Wild-type SNORA81, but not a guide-region mutant, restores proliferation. Together, these findings support a "sno-balling" model in which altered abundance of a single snoRNA propagates through rRNA modification, selective ribosome engagement and protein output to reshape cancer-associated gene expression and cell behavior.
- organism: human
- assay: Ribo-seq
- research focus: differential expression
- research focus: cell type annotation
- research focus: gene regulatory network inference
- research focus: drug response / drug discovery
- approach: statistical model
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- A Ribosomal RNA modification regulates translation of PI3K/AKT activators in high-grade serous ovarian carcinoma
Andrew Rivera, Laurence Faucher‐Giguère, … Sherif Abou Elela·bioRxiv·Oct 7, 2026
- An RNA-binding switch drives ribosome biogenesis and tumorigenesis downstream of RAS oncogene
M. S. Azman, M. Dodel, … F. K. Mardakheh·bioRxiv·Dec 16, 2021
- Loss of macp{Psi} ribosomal RNA modification is a major feature of cancer
A. Babaian, K. Rothe, … D. L. Mager·bioRxiv·Feb 6, 2020
- The retinoblastoma tumor suppressor limits ribosomal readthrough during oncogene induced senescence
Neylen Del Toro, Frédéric Lessard, … Gerardo Ferbeyre·Biology OpenPeer-reviewed·Oct 22, 2021
- FUS modulates the level of ribosomal RNA modifications by regulating a subset of snoRNA expression
Kishor Gawade, Patrycja Plewka, … Katarzyna Dorota Raczyńska·Scientific ReportsPeer-reviewed·Feb 20, 2023
- High-grade Ovarian Cancer Associated H/ACA snoRNAs Promote Cancer Cell Proliferation and Survival
L. Faucher-Giguere, A. Roy, … S. Abou Elela·bioRxiv·Aug 24, 2021